SCHEMBL4515766

SCHEMBL4515766

Cc1ccc(C(=O)OCCN(C)C)cc1-n1c(C)cc(OCc2ccccc2CNC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(OCCO)c2)c(Cl)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.41
MAPK11 Q15759 3/20 0.38
MAPK13 O15264 2/20 0.38
MAPK12 P53778 2/20 0.38
FLT1 P17948 1/20 0.37
MINK1 Q8N4C8 1/20 0.37
CDK8 P49336 3/20 0.36
RET P07949 2/20 0.36
PDGFRA P16234 2/20 0.36
MAPK9 P45984 2/20 0.36
PKN2 Q16513 1/20 0.36
NTRK2 Q16620 2/20 0.35
NTRK1 P04629 1/20 0.35
GRK5 P34947 1/20 0.35
PRKX P51817 1/20 0.35
TYRO3 Q06418 1/20 0.35
PRKAA1 Q13131 1/20 0.35
ROCK1 Q13464 1/20 0.35
TAOK1 Q7L7X3 1/20 0.35
GSK3A P49840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505553 0.94 MAPK14 (0.40) MAPK14MAPK11MAPK12RETMAPK9
SCHEMBL4520556 0.94 MAPK14 (0.41) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL4499671 0.93 MAPK14 (0.43) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL13678591 0.92 MAPK14 (0.43) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL4508389 0.91 MAPK14 (0.44) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL4505864 0.90 MAPK14 (0.43) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL4516827 0.90 MAPK14 (0.42) MAPK14MAPK11MAPK12RETMAPK9
SCHEMBL4506806 0.90 MAPK14 (0.44) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL13678590 0.89 MAPK14 (0.45) MAPK14MAPK11MAPK13MAPK12FLT1
SCHEMBL13678613 0.88 MAPK14 (0.44) MAPK14MAPK11MAPK13MAPK12FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
EP-1987022-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES Pfizer Products Inc. (US) 2008-11-05 EP disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 MAPK14 117/4885MAPK11 404/4885MAPK13 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.